Understanding CAR T Therapy: A Groundbreaking Approach to Myeloma Treatment

In this video, IMF Chairman of The Board Dr. Brian G.M. Durie and IMF Chief Medical Officer Joseph Mikhael, MD, along with other myeloma experts, discuss the importance of CAR T Therapy as an innovative and groundbreaking approach to the treatment of multiple myeloma.
_______________
Improving Lives | Finding the Cure
In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF! bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard KZbin License
In most cases, captions are autogenerated by KZbin.

[@vikingwind25]

Thank you so much for this video and all the work the IMF does. Question: Is Stem cell collection the same as T cell collection needed for CAR-T cell therapy? Can I use this Stem Cell collection for CAR-T cell manufacturing?